Support cancer treatment with immunotherapy
Immunotherapy has revolutionized the management of many types of cancer. New agents can now "take the blindfold off" the immune system so it can reject the patient's cancer as it was originally programmed to do.
While this exciting cutting-edge therapy doesn’t treat cancer, it does treat a dysfunctional immune system. It also adds to our collection of cancer treatments such as:
- Molecular therapy
- Targeted therapy
- Endocrine therapy
- Radiation therapy
This webinar will outline new immunotherapies in their approved role to treat various cancers before or after surgery and for advanced cancers. Key audiences include those involved with clinical policy, processes and solutions at health plans, employers and brokers.
Presented in partnership with 2nd.MD.
Dr. William Flood (Moderator), Senior Medical Director, Cancer Guidance Program and Specialty Pharmacy, Optum Health Solutions
Dr. Charles Balch (2nd.MD panel specialist), Professor, Department of Surgical Oncology — Research, Division of Surgery, The University of Texas MD Anderson Cancer Center
Dr. Elizabeth Buchbinder (2nd.MD panel specialist), Melanoma Disease Center, Department of Medical Oncology Assistant Professor of Medicine, Harvard Medical School
Please complete the form to view the webinar